Together we will beat cancer

Donate

News digest – lockdown, ovarian cancer blood test, statins and Government spending review

As many as 50,000 people in the UK have an undiagnosed cancer as a result of the disruption caused by coronavirus, according to Macmillan Cancer Support.

Read More

An existing blood test for ovarian cancer has been re-evaluated. The results are in

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

Read More

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here’s why it’s time to invest in cancer services and research.

Read More

Sugar and cancer – what you need to know

We tackle the myth that sugar ‘feeds’ cancer cells, and explore how the amount of sugar in our diets is cause for concern due to obesity.

Read More

News digest – targeted radiation beam, precision medicine and our early detection roadmap

A new technique has been developed to help reduce a common side effect of radiotherapy for people with throat cancer.

Read More

Dear Prime Minister: “Please don’t delay action again, we’re counting on you”

Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review.

Read More

Creating a shared vision to detect cancer earlier

We’re bringing researchers, policy-makers, pharmaceutical
companies and the public together to find a way to make early diagnosis better.

Read More

We’re asking scientists to tackle 9 of the toughest challenges in cancer research

This entry is part 25 of 25 in the series Cancer Grand Challenges

We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.

Read More

NHS staff shortages: What’s needed to build a sustainable cancer workforce?

We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.

Read More

News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment

Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years.”

Read More